| Overall, N = 304 (100%) | Recipient underweight N = 41 (13%) | Recipient normal weight N = 130 (43%) | Recipient overweight/obesity, N = 133 (44%) | p value |
---|---|---|---|---|---|
At admission in ICU | |||||
 SAPS II score, med [IQR] | 44 [39–53] | 44 [37–50] | 44 [38–52] | 44 [39–54] | 0.28 |
 SOFA score, med [IQR] | 8 [6–10] | 8 [6–9] | 8 [6–10] | 8 [7–10] | 0.23 |
 Lactatemia > 3 mmol/L, n (%) | 108 (36) | 16 (39) | 42 (32) | 50 (38) | 0.59 |
 Lactatemia > 2 mmol/L, n (%) | 185 (61) | 29 (71) | 76 (58) | 80 (60) | 0.36 |
Hemodynamic status during hospitalization in ICU | |||||
 Duration of catecholamine administration, days, med [IQR] | 2 [1–4] | 2 [1–3.5] | 2 [1–4] | 2 [1–5] | 0.28 |
 ECMO support after surgery, n (%) | 64 (21) | 9 (22) | 21 (16) | 34 (26) | 0.17 |
 Duration of ECMO support, days, med [IQR] | 0 [0–2] | 0 [0–1] | 0 [0–2] | 0 [0–2] | 0.15 |
 Atrial fibrilation, n (%) | 114 (38) | 12 (29) | 46 (36) | 56 (43) | 0.25 |
 MOF syndrome, n (%) | 100 (33) | 14 (34) | 39 (30) | 47 (36) | 0.59 |
Respiratory complications | |||||
 Duration of MV, med [IQR] | 3 [1–17] | 3[1–12] | 3 [1–10] | 4 [1–26] | 0.091 |
 PGD, n (%) | 161 (53) | 17 (41) | 60 (46) | 84 (63) | 0.006 |
 Grade 3 PGD | 117 (38) | 14 (34) | 40 (31) | 63 (47) | 0.018 |
 NBA during hospitalization in ICU, n (%) | 89 (29) | 8 (20) | 30 (23) | 51 (39) | 0.008 |
 Duration of NBA administration, days, med [IQR] | 0 [0–1] | 0 [0–0] | 0 [0–1] | 0 [0–2] | 0.020 |
 Prone positionning, n (%) | 43 (14) | 2 (5) | 13 (10) | 28 (21) | 0.007 |
 Number of sessions of prone positionning, med [IQR] | 0 [0–0] | 0 [0–0] | 0 [0–0] | 0 [0–0] | 0.011 |
 Extubation failure, n (%) | 55 (22) | 9 (27) | 27 (25) | 19 (18) | 0.43 |
 Tracheostomy for ventilation weaning, n (%) | 85 (28) | 9 (22) | 27 (21) | 49 (37) | 0.008 |
Infectious complications | |||||
 Septic shock, n (%) | 90 (30) | 9 (22) | 35 (27) | 46 (35) | 0.19 |
 Number of pneumonias, med [IQR] | 1 [1, 2] | 1 [1, 2] | 1 [1, 2] | 1 [1, 2] | 0.41 |
Renal complications | |||||
 AKI, n (%) | 145 (48) | 21 (51) | 59 (46) | 65 (49) | 0.82 |
 KDIGO score, med [IQR], n (%) | 1 [0–2] | 1 [0–2] | 1 [0–2] | 1 [0–3] | 0.29 |
 KDIGO 3, n (%) | 60 (20) | 9 (22) | 17 (13) | 34 (26) | 0.036 |
 Renal replacement therapy, n (%) | 48 (16) | 7 (17) | 14 (11) | 27 (20) | 0.11 |
Surgical complications | |||||
 Thoracic surgical reintervention, n (%) | 61 (20) | 7 (17) | 25 (19) | 29 (22) | 0.77 |
 Abdominal surgery, n (%) | 31 (10) | 6 (15) | 8 (6) | 17 (13) | 0.10 |
Other complications | |||||
 Bonchial anastomotic dehiscence, n (%) | 40 (16) | 2 (6) | 14 (13) | 24 (21) | 0.072 |
 Antibody-mediated rejection, n (%) | 81 (27) | 10 (24) | 32 (25) | 39 (30) | 0.62 |
 Acute cellular rejection, n (%) | 40 (13) | 5 (12) | 13 (10) | 22 (17) | 0.28 |
Outcome | |||||
 Duration of ICU stay, days, med [IQR] | 17 [9–31] | 18 [10–28] | 15 [10–26] | 18 [11–41] | 0.15 |
 Death on day-90, n (%) | 52 (17) | 5 (12) | 24 (18) | 23 (17) | 0.65 |
 Death at one year, n (%) | 86 (28) | 9 (22) | 37 (28) | 40 (30) | 0.60 |